Table 3.
(Unit: USD) | |||
---|---|---|---|
GEM-E | GEM | p-valuea | |
(n = 1,331) | (n = 2,936) | ||
Inpatient cost (Mean ± SD)b | 14,846.70 ± 11,865.27 | 13,211.07 ± 1,0931.57 | <0.0001 |
Length of stay (Mean ± SD) | 64 ± 53 | 63 ± 54 | 0.8032 |
Outpatient cost (Mean ± SD)b | 6,152.29 ± 7,233.05 | 6,066.95 ± 7,001.03 | 0.6920 |
Medication cost (Mean ± SD)b | 3,264.00 ± 4,579.44 | 1,169.20 ± 1,644.40 | <0.0001 |
Total medical costs (Mean ± SD)b | 23,819.51 ± 15,106.18 | 19,927.98 ± 14,444.86 | <0.0001 |
Abbreviation: GEM Gemcitabine, GEM-E Gemcitabine + Erlotinib
aDifferences between GEM and GEM-E was tested with t-test after log transformation
bAverage 2013 exchange rate: one US dollar (USD) = 1,113.85 Korea Won (KRW)